BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28039710)

  • 1. Clinicopathological features and prognosis of Borrmann type IV gastric cancer.
    Zhu YL; Yang L; Sui ZQ; Liu L; Du JF
    J BUON; 2016; 21(6):1471-1475. PubMed ID: 28039710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?
    Liu Y; Chen XH; Meng XH; Liu CF; Zhao LL; Han JW; Zhuang LW
    Hepatogastroenterology; 2012; 59(114):623-6. PubMed ID: 22024039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].
    Chen L; Wei S; Ye Z; Wang Y; Zheng Q; Zhuo C; Xiao J; Zeng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):67-72. PubMed ID: 28105623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic features and prognostic analyses of Borrmann type IV gastric cancer].
    Ma JP; Chen JH; Cai SR; Chen CQ; Yang DJ; Wu H; He YL; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2534-7. PubMed ID: 23158792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
    Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
    Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
    Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
    Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
    Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borrmann type IV: an independent prognostic factor for survival in gastric cancer.
    An JY; Kang TH; Choi MG; Noh JH; Sohn TS; Kim S
    J Gastrointest Surg; 2008 Aug; 12(8):1364-9. PubMed ID: 18516653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological features of patients with Borrmann type IV gastric carcinoma.
    Kim DY; Kim HR; Kim YJ; Kim S
    ANZ J Surg; 2002 Oct; 72(10):739-42. PubMed ID: 12534387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
    Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
    Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis analysis of 310 patients with pathological stage pN3 gastric cancer].
    Ke B; Liu N; Liang H; Zhang RP; Wang XJ; Wu LL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):543-6. PubMed ID: 23801207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rationality of N3 classification and its sub-classification in TNM classification system for advanced gastric cancer].
    Cheng Y; Huang J; Zhu Z; Xu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):749-55. PubMed ID: 27452751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic predictors of patients with carcinoma of the gastric cardia.
    Zhang M; Li Z; Ma Y; Zhu G; Zhang H; Xue Y
    Hepatogastroenterology; 2012 May; 59(115):930-3. PubMed ID: 22469742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borrmann type IV gastric cancer should be classified as pT4b disease.
    Huang JY; Wang ZN; Lu CY; Miao ZF; Zhu Z; Song YX; Xu HM; Xu YY
    J Surg Res; 2016 Jun; 203(2):258-67. PubMed ID: 27363630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.